-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$16.00532.41% Upside
Esperion Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. has been rated by research analysts at Needham, Wells Fargo in the past 90 days.